跳至主要内容
临床试验/NCT07305636
NCT07305636已完成不适用

Assessing the Utility of AI Models in MAFLD Diagnosis: Comparison With Traditional Non-Invasive Fibrosis Scores.

Tanta University1 个研究点 分布在 1 个国家目标入组 522 人开始时间: 2025年5月13日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
522
试验地点
1
主要终点
Measure diagnostic accuracy of AI models in predicting hepatic fibrosis stage (F0-F4)

研究概览

简要总结

This study evaluates the accuracy of artificial intelligence (AI) models using FibroScan and clinical data to predict hepatic fibrosis in Egyptian patients with metabolic-associated fatty liver disease (MAFLD). The performance of the AI models will be compared with conventional noninvasive fibrosis scores (FIB-4, APRI, NAFLD fibrosis score, and FAST). The goal is to improve early, noninvasive diagnosis of fibrosis and reduce reliance on liver biopsy.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Days 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - Adults ≥18 years.
  • Diagnosed with MAFLD according to international criteria (hepatic steatosis with metabolic dysfunction).
  • Valid FibroScan evaluation with available LSM and CAP values.

排除标准

  • Excessive alcohol intake (>30 g/day for men, >20 g/day for women).
  • Chronic viral hepatitis (HBV or HCV).
  • Autoimmune hepatitis.
  • Known malignancy.
  • Refusal to participate.

结局指标

主要结局

Measure diagnostic accuracy of AI models in predicting hepatic fibrosis stage (F0-F4)

时间窗: At enrollment (single cross-sectional assessment).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nahla Ahmed Khalaf

Lecturer of Tropical Medicine and Infectious diseases

Tanta University

研究点 (1)

Loading locations...

相似试验